Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C34H31F3N2O3 |
Molecular Weight | 572.6167 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@](N1CCC(CC1)C2=CC=C(NC(=O)C3=C(C=CC=C3)C4=CC=C(C=C4)C(F)(F)F)C=C2)(C(=O)OC)C5=CC=CC=C5
InChI
InChIKey=WSYALRNYQFNNGP-WJOKGBTCSA-N
InChI=1S/C34H31F3N2O3/c1-42-33(41)31(26-7-3-2-4-8-26)39-21-19-24(20-22-39)23-13-17-28(18-14-23)38-32(40)30-10-6-5-9-29(30)25-11-15-27(16-12-25)34(35,36)37/h2-18,24,31H,19-22H2,1H3,(H,38,40)/t31-/m1/s1
Johnson and Johnson was developing usistapide, a microsomal triglyceride transfer protein (MTTP) inhibitor, for the treatment of obesity and type 2 diabetes. Usistapide, also known as JNJ-16269110 and R256918, has been used in trials studying the treatment of obesity, overweight, metabolic diseases, nutrition disorders, and nutritional and metabolic diseases. Usistapide was removed from the company pipeline and appears to have been discontinued.
Originator
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29728
Created by
admin on Fri Dec 15 18:12:11 GMT 2023 , Edited by admin on Fri Dec 15 18:12:11 GMT 2023
|
||
|
NCI_THESAURUS |
C29711
Created by
admin on Fri Dec 15 18:12:11 GMT 2023 , Edited by admin on Fri Dec 15 18:12:11 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
WW-160
Created by
admin on Fri Dec 15 18:12:11 GMT 2023 , Edited by admin on Fri Dec 15 18:12:11 GMT 2023
|
PRIMARY | |||
|
9364
Created by
admin on Fri Dec 15 18:12:11 GMT 2023 , Edited by admin on Fri Dec 15 18:12:11 GMT 2023
|
PRIMARY | |||
|
403989-79-7
Created by
admin on Fri Dec 15 18:12:11 GMT 2023 , Edited by admin on Fri Dec 15 18:12:11 GMT 2023
|
PRIMARY | |||
|
C152809
Created by
admin on Fri Dec 15 18:12:11 GMT 2023 , Edited by admin on Fri Dec 15 18:12:11 GMT 2023
|
PRIMARY | |||
|
DTXSID30193393
Created by
admin on Fri Dec 15 18:12:11 GMT 2023 , Edited by admin on Fri Dec 15 18:12:11 GMT 2023
|
PRIMARY | |||
|
73YSY3U094
Created by
admin on Fri Dec 15 18:12:11 GMT 2023 , Edited by admin on Fri Dec 15 18:12:11 GMT 2023
|
PRIMARY | |||
|
DB12414
Created by
admin on Fri Dec 15 18:12:11 GMT 2023 , Edited by admin on Fri Dec 15 18:12:11 GMT 2023
|
PRIMARY | |||
|
100000177637
Created by
admin on Fri Dec 15 18:12:11 GMT 2023 , Edited by admin on Fri Dec 15 18:12:11 GMT 2023
|
PRIMARY | |||
|
CHEMBL2103860
Created by
admin on Fri Dec 15 18:12:11 GMT 2023 , Edited by admin on Fri Dec 15 18:12:11 GMT 2023
|
PRIMARY | |||
|
56842069
Created by
admin on Fri Dec 15 18:12:11 GMT 2023 , Edited by admin on Fri Dec 15 18:12:11 GMT 2023
|
PRIMARY |
ACTIVE MOIETY